SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System

SI-BONE, Inc. (SIBN) has recently received FDA 510(k) clearance for its iFuse TORQ TNT implant system ("TNT"). The TNT implant system is the first anatomy-specific system designed to meet the biomechanical challenges presented by pelvic fragility fractures. FDA has determined that TNT has the potential to provide more effective treatment of pelvic fragility fractures than the current standard of care, such as cannulated screws. The latest development highlights SI-BONE's capability to develop a platform of ...